Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stress Cardiac MRI Using Regadenoson for Evaluation of Nonspecific Allograft Dysfunction

NCT02597543 is registered in ClinicalTrials.gov with Paul Kim as lead sponsor.

NCT NCT02597543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02597543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stress Cardiac MRI Using Regadenoson for Evaluation of Nonspecific Allograft Dysfunction
Lead sponsor
Paul Kim
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
June 30, 2016
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute graft rejection, chronic graft rejection, heart transplant